FindTrial
Sign In

NA - FACIL-2

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2018-003635-30-FR
Enrollment
10
Registered
2018-10-19
Start date
2019-01-25
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NA MedDRA version: 20.0 Level: LLT Classification code 10079174 Term: Early miscarriage System Organ Class: 100000004868

Interventions

Trade Name: Proleukin Product Name: Proleukin Product Code: L03A-CO1 Pharmaceutical Form: Powder for concentrate for solution for injection/infusion INN or Proposed INN: aldesleukine CAS Number: 1109

Sponsors

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 10 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Main Objective: NA;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA—

Secondary

MeasureTime frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA—

Countries

France

Contacts

Public ContactCHEF DE PROJET

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)

karine.seymour@aphp.fr33144841742

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026